Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study

Abstract

Objective:

To assess the effects of soybean-derived pinitol on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus.

Design:

Randomized, double-blind, placebo-controlled, parallel-group trial.

Setting:

Pusan Paik Hospital, Pusan, Republic of Korea.

Interventions:

A total of 30 patients with type II diabetes received an oral dose of 600 mg soybean-derived pinitol or placebo twice daily for 13 weeks.

Results:

Pinitol significantly decreased mean fasting plasma glucose, insulin, fructosamine, HbA1c, and the homeostatic model assessment insulin resistance index (HOMA-IR, P<0.001). Pinitol significantly decreased total cholesterol, LDL-cholesterol, the LDL/HDL-cholesterol ratio, and systolic and diastolic blood pressure and increased HDL-cholesterol (P<0.05).

Conclusions:

These data suggest that soybean-derived pinitol may be beneficial in reducing cardiovascular risk in Korean type II diabetes.

Sponsorship:

This study was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (HMP 02-PJ1-PG3-22005-0011).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • American Diabetes Association (1999): Management of dyslipidemia in adults with diabetes (Position Statement). Diabetes Care 22 (s01), 56–59.

  • Bates SH, Jones RB & Bailey CJ (2000): Insulin-like effect of pinitol. Br. J. Pharmacol. 130, 1944–1948.

    Article  CAS  Google Scholar 

  • Davis A, Christinansen M, Horowitz JF, Klein S, Hellerstein MK & Ostlund Jr RE (2000): Effect of pinitol treatment on insulin action in subjects with insulin resistance. Diabetes Care 23, 1000–1005.

    Article  CAS  Google Scholar 

  • Garber AJ (2003): Metformin and vascular protection: a diabetologist's view. Diabetes Metab 29 (Suppl 6), 113–116.

    Google Scholar 

  • International Atherosclerosis Society (IAS) (2003): Harmonized clinical guidelines on prevention of atherosclerotic vascular disease. Exec. Summ. 8.

  • Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P & Inoue S (2002): Criteria and classification of obesity in Japan and Asia-Oceania. Asia Pacific J. Clin. Nutr. 11, S732–S737.

    Article  Google Scholar 

  • Korean Dietitian Society (2000): Manual of Medical Nutrition Therapy, pp 180–216. Kyunghee Total Printing Co.: Seoul.

  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC (1985): Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419.

    Article  CAS  Google Scholar 

  • Narayanan CR, Joshi DD, Mujumdar AM & Dhekne VV (1987): Pinitol—a new anti-diabetic compound from the leaves of Bougainvillea spectabilis. Curr. Sci. 56, 139–141.

    CAS  Google Scholar 

  • Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD & Allan G (1999): Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N. Engl. J. Med. 340, 1314–1320.

    Article  CAS  Google Scholar 

  • O'Keefe JH, Miles JM, Harris WH, Moe RM & McCallister BD (1999): Improving the adverse cardiovascular prognosis of type 2 diabetes. Mayo Clin. Proc. 74, 171–180.

    Article  Google Scholar 

  • Ostlund RE & Sherman WR (1996): United States Patent. Patent Number 5,550,166.

  • Shin YC, Jeon YJ, Kim JJ & Choi CM (2001): Korea Patent. Application Number 1020010016111.

  • UK Prospective Diabetes Study (UKPDS) Group (1998): Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ 317, 703–713.

  • Varela-Nieto I, Leon Y & Caro HN (1996): Cell signalling by inositol phosphoglycans from different species. Comp. Biochem. Physiol. 115, 223–241.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to Amicogen, Inc. (Jinju, Korea), for providing the soybean-derived pinitol.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J C Kim.

Additional information

Guarantor: J-I Kim.

Contributors: JCK was involved in study design. J-IK contributed to the practical organization of the trial. M-JK and M-SL were responsible for biochemical analyses. J-JK was responsible for design and statistical analyses. I-JC was responsible for project management. JCK and J-IK wrote the first draft of the paper and all authors contributed to the final draft.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, JI., Kim, J., Kang, MJ. et al. Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study. Eur J Clin Nutr 59, 456–458 (2005). https://doi.org/10.1038/sj.ejcn.1602081

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ejcn.1602081

Keywords

This article is cited by

Search

Quick links